Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
8,504
-
Share change
-
+8,504
-
Total reported value
-
$44,406
-
Price per share
-
$5.50
-
Number of holders
-
5
-
Value change
-
+$44,406
-
Number of buys
-
5
Institutional Holders of Coeptis Therapeutics Holdings, Inc. - COM NEW (COEP) as of Q4 2024
As of 31 Dec 2024,
Coeptis Therapeutics Holdings, Inc. - COM NEW (COEP) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,504 shares.
The largest 5 holders included
UBS Group AG, Steward Partners Investment Advisory, LLC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and Semmax Financial Advisors Inc..
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.